A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

Recruiting

Phase 2

TEV-56286A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

Sponsor:

Teva Branded Pharmaceutical Products R&D LLC

Code:

NCT06568237

Conditions

Multiple System Atrophy

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

TEV-56286

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-03. This information was provided to ClinicalTrials.gov by Teva Branded Pharmaceutical Products R&D LLC on 2026-02-27.